Variant report
Variant | esv3369966 |
---|---|
Chromosome Location | chr2:114867182-114869130 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs140052797 | chr2:114867225-114867226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs115474910 | chr2:114867233-114867234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs181951777 | chr2:114867238-114867239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs570964014 | chr2:114867269-114867270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs59349616 | chr2:114867290-114867291 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs553626127 | chr2:114867368-114867369 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs567237639 | chr2:114867371-114867372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs535893990 | chr2:114867382-114867383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs72956294 | chr2:114867411-114867412 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs565680779 | chr2:114867480-114867481 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs145384772 | chr2:114867498-114867499 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs545181754 | chr2:114867525-114867526 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs558783656 | chr2:114867566-114867567 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs572189258 | chr2:114867568-114867569 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs369473672 | chr2:114867655-114867656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs540709368 | chr2:114867681-114867682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs560413494 | chr2:114867689-114867690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs529259476 | chr2:114867707-114867708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs542671456 | chr2:114867708-114867709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs562802534 | chr2:114867712-114867713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs72956297 | chr2:114867742-114867743 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs11366625 | chr2:114867819-114867820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs398042600 | chr2:114867830-114867831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs189282356 | chr2:114867832-114867833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs116113225 | chr2:114867843-114867844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs544597819 | chr2:114867877-114867878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs377727038 | chr2:114867906-114867907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs202214685 | chr2:114867925-114867926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs112684564 | chr2:114867926-114867927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs71852406 | chr2:114867927-114867928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs200257030 | chr2:114867928-114867929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs369362961 | chr2:114867929-114867930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs373233030 | chr2:114867930-114867931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs574977201 | chr2:114867940-114867941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs71925521 | chr2:114867942-114867943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs373046080 | chr2:114867943-114867944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs376762340 | chr2:114867954-114867955 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs375610626 | chr2:114867957-114867958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs536129889 | chr2:114867966-114867967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs181235722 | chr2:114867980-114867981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs201959899 | chr2:114867983-114867984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs560639155 | chr2:114867984-114867985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs72374725 | chr2:114867997-114867998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs186507750 | chr2:114868005-114868006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs191817259 | chr2:114868006-114868007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs369913364 | chr2:114868018-114868019 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs373126663 | chr2:114868022-114868023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs71420250 | chr2:114868036-114868037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs554400939 | chr2:114868062-114868063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs376588184 | chr2:114868063-114868064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroticism | 17667963 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:114865400-114867400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
2 | chr2:114866000-114867200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr2:114866000-114867400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr2:114866000-114867400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr2:114866000-114867600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr2:114866200-114867400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr2:114866200-114867400 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
8 | chr2:114866200-114867400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
9 | chr2:114866400-114867400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr2:114866400-114867400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
11 | chr2:114866400-114867400 | Enhancers | Aorta | Aorta |
12 | chr2:114866600-114867200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
13 | chr2:114866600-114867400 | Enhancers | H1 Cell Line | embryonic stem cell |
14 | chr2:114866600-114867400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
15 | chr2:114866800-114867200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
16 | chr2:114866800-114867200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
17 | chr2:114867400-114870800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
18 | chr2:114867600-114870600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |